Egyptian International Pharmaceutical Industries Company reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EGP 1,734.04 million compared to EGP 1,548.09 million a year ago. Net income was EGP 304.09 million compared to EGP 235.9 million a year ago.